12345678

INTRODUCTION

We in America are involved in a massive social blunder in our handling of
the drug problem. In consequence, drugs are readily available everywhere,
consumption rates are high, our indices of social pathology soar above those of
all the other countries of the industrialized world, and we burden the American
economy with costs that threaten our future economic competitiveness.

The common apology for the failure of drug control is the myth that we are
doing the best we can with an intractable problem. Some critics answer that myth
with another, according to which the failure of drug control measures requires
the legalization of drug commerce. This booklet contradicts both of those myths.
Both myths are disproved by the fact that, while American drug control
measures have foundered, other countries are solving the allegedly intractable
drug problem, and they are doing it in the context of general drug prohibition.
The important lesson to be drawn from their experience has little to do with
legality or illegality. Rather, the lesson is that great gains against the drug/crime
epidemic are attainable through harm reduction and public health measures we
in the United States have failed to employ.

This pamphlet analyzes and explains the successful experience. It
generalizes from it, and systematizes it into a comprehensive public health
strategy for control of the drug/crime epidemic. The resulting strategy is
variously called public interest interposition, market interposition, public health
interposition
and, simply, interposition. Each of those names tells something
valid about the character of this strategy. Regardless of name, the strategy is
theoretically complete now and ready for implementation as soon as public
consent can be secured.

* * *

As to the last-named problem, a "conversion hypothesis" is provided
(toward the end of Part II of this pamphlet) to explain how public consent for
interposition can be obtained. An essential precondition of the conversion is the
emergence of a national drug policy leadership group for interposition. This
group must be drawn from the several intelligentsias that have special
information and expertise to contribute to formation of a future workable,
rational and humane drug policy. These are the same intelligentsias to whom
the public will look for guidance in the drug policy field. Because interposition is
a public health solution, the initiative for formation of the national drug policy
leadership group must come from the public health profession. Before the other
intelligentsias will play their critically important roles, public health
professionals must come forth, proclaiming the competence of their profession
to control the drug/crime epidemic and petitioning society to be given the tools
of interposition to work with.